NSDB News
Carolina Cancer Nanotechnology Training program assembles large video library for learning about Cancer Nanotechnology
January 15, 2019
The Carolina Cancer Nanotechnology Training Program (CCNTP) T32 program at UNC – Chapel Hill has prepared a video library of 90+ recorded lectures and seminars from the Carolina Nanoformulation Workshop and seminar speakers who have visited UNC – Chapel Hill. The library includes videos addressing the topics of: Cancer Biology, Types of Nanoformulations, Pharmacokinetics and Pharmacodynamics, Computer & Animal Models for Evaluating Efficacy of Nanoformulations, Regulatory Considerations for Nanoformulations, Clinical & Translational Aspects, Informatics & Statistics, and Recorded Lab Demonstrations. The videos are relevant to researchers working in nanomedicine, pharmacoengineering, basic cancer research, and clinical translational sciences.
We would like to share this video library with T32 and cancer nanotechnology-focused colleagues. Visit the site at cancernano.web.unc.edu. Email cancernano@unc.edu
to request the site password.
Alliance researchers build army of metal-organic nanoflowers to treat cancer
March 29, 2018
Wenbin Lin, PI for the University of Chicago IRCN, has recently entered his nanotechnology platform based off metal-organic frameworks, into Phase I clinical trials. His recent publication in Nature Biomedical Engineering led to the primary candidate now undergoing human testing.
NCI-sponsored Systems Biology and Physical Oncology Undergraduate Summer Research Opportunity
December 12, 2017
The National Cancer Institute’s (NCI) Cancer Systems Biology Consortium and Physical Sciences in Oncology Network are offering rising Junior and Senior undergraduates with outstanding research potential the opportunity to work closely with faculty mentors from NCI-supported institutions for an 8-week summer fellowship. The 2017 summer research program is designed specifically for students to gain experience in the interdisciplinary fields of systems biology and physical oncology. Students who are especially interested in cancer research careers are encouraged to apply. Opportunities are available at 14 research institutions across the United States. Stipend, housing, and travel to and from the host institution are covered by NCI. Additionally, students will convene at the NIH in Bethesda, MD, mid-way through the summer to present their research and network with their peers.
Detailed information about the program and application instructions can be found at: https://ncifrederick.cancer.gov/SummerProgram/. The application deadline is February 16, 2018.
Wayne's TED Talk Has More Than 300K Views in First Week
October 17, 2017
Congratulations to the UNC CNTC post-doctoral fellow, Dr. Elizabeth Wayne, who delivered a TED talk in April 2017 titled "We can hack our immune cells to fight cancer." After posting on the TED main website October 17, 2017 it has already been viewed more than 340,000 times.
2017 International Institute for Nantechnology Symposium
August 1, 2017
Join world experts for nanotechnology in medicine at this year’s 2017 IIN Symposium. Held in Evanston, IL September 28, 2017 --- 8:30 am to 5:30 pm. Registration is free although registration is required beforehand and will fill up fast. See the IIN website for details and registration.
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
May 12, 2017
Chad Mirkin, PI, of the Northwestern University CCNE has entered his spherical nucleic acid nano platform into Phase 0 clinical trials. The patient population targeted for this trial is patients with the highly aggressive form of brain cancer, glioblastoma multiforme. The platform has shown much success in crossing the highly selective blood-brain barrier and represents a novel solution to a very important problem in treating CNS disease and disorders.
NCI Launches Next Phase of Alliance for Nanotechnology in Cancer Program
September 4, 2015
The National Cancer Institute (NCI) has again awarded several five-year, multi-institution grants in continued support of its Alliance for Nanotechnology in Cancer program. Given the progress to date of the Alliance, the NCI approved a third phase of the program with a sizable investment in funding. The Alliance program is dedicated to using nanotechnology solutions towards solving cancer biology and oncology problems as well as developing new cancer interventions based on nanotechnology. The program was established in 2004 and funds efforts at academic centers which are engaged in research and translation of new technologies to the clinical environment.